Proteinuria: An underappreciated risk factor in cardiovascular disease
Rent the article at a discountRent now
* Final gross prices may vary according to local VAT.Get Access
Changes in renal function produced by hypertension appear to be associated with higher cardiovascular morbidity and mortality. Indices of altered renal function (eg, micro-albuminuria, increased serum creatinine concentrations, decrease in estimated creatinine clearance, or overt proteinuria) are independent predictors of cardiovascular morbidity and mortality. The Framingham Heart Study documented the relevance of proteinuria for cardiovascular prognosis in the community. The International Nifedipine GITS study: Intervention as a goal in Hypertension Treatment (INSIGHT) study assessed the role of proteinuria as a very powerful risk factor. Several studies demonstrated that microalbuminuria is a predictor of cardiovascular disease. It has been shown that the presence of microalbuminuria in primary hypertension carries an elevated cardiovascular risk. Furthermore, recent data indicate that even minor derangements of renal function are associated with an increase in cardiovascular risk factors, and promote progression of atherosclerosis. All these parameters should routinely be evaluated in clinical practice, and in the future must be considered in any stratification of cardiovascular risk in hypertensive patients.
References and Recommended Reading
Rostand SG, Brunzell JD, Cannon RO, et al.: Cardiovascular complications in renal failure. J Am Soc Nephrol 1991, 2:1053–1058.PubMed
Ruilope LM, Salvetti A, Jamerson K, et al.: Renal function and intensive lowering of blood pressure in the hypertensive subjects of the Hypertension Optimal Treatment (HOT) Study. J Am Soc Nephrol 2001, 12:218–225. This paper confirms the predictive value of serum creatinine previously demonstrated in the HDFP study.PubMed
Brown MJ, Palmer CR, Castaigne A, et al.: Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a goal in Hypertension Treatment (INSIGHT). Lancet 2000, 356:366–372. Proteinuria was found to be a very potent predictor of cardiovascular risk in essential hypertension.PubMedCrossRef
Mann JFE, Gerstein HC, Pogue J, et al.: Renal insufficiency as predictor of cardiovascular outcomes and impact of ramipril: the HOPE randomization trial. Ann Intern Med 2001, 134:629–636. This article reviews the relevance of renal function derangement, in particular of microalbuminuria as a predictor of prognosis, and also as a predictor of the response to ramipril.PubMed
Hillege HL, Girbes ARJ, de Kam PJ, et al.: Renal function, neurohumoral activation, and survival in patients with chronic heart failure. Circulation 2000, 102:203–210.PubMed
Levey AS, Bosch JP, Lewis JB, et al.: A more accurate method to estimate glomerular rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461–470.PubMed
Minram A, Ribstein J, DuCalair G: Is microalbuminuria a marker of early intrarenal vascular dysfunction in essential hypertension? Hypertension 1994, 23:1018–1021.
Lindeman R, Tobin J, Shock NW: Longitudinal studies on the rate of decline in renal function with age. J Am Geriat Soc 1985, 33:278–285.PubMed
Segura J, Campo C, Rodicio JL, Ruilope LM: How relevant and frequent is the presence of mild renal insufficiency in essential hypertension? J Clin Hypertens 2002, in press. This paper contains data on the frequency of renal damage, and in particular of proteinuria in patients followed in an in-hospital hypertension unit.
Samuelsson O: Hypertension in middle-aged man: management, morbidity and prognostic factors during long-term hypertensive care. Acta Med Scand 1985, 702:1–79.
Ruilope LM, Rodicio JL: Microalbuminuria in clinical practice. Kidney: A Current Survey of World Literature 1995, 4:211–216.
Holtzman NA, Marteau TM: Will genetics revolutionize medicine? N Eng J Med 2000, 343:141–144.CrossRef
Watchell K, Olsen MH, Dahlof B, et al.: Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. J Hypertens 2002, 20:405–412. An interesting paper describing the relationship of microalbuminuria and the different forms of LVH.CrossRef
Gerstein HC, Mann JF, Yi Q, et al., for the HOPE Study Investigators: Albuminuria and risk of cardiovascular events, death and heart failure in diabetic and nondiabetic individuals. JAMA 2001, 286:421–426. This article shows that the lower limit of microalbuminuria in relation to risk is not the usual cut-off point of 30 mg/d.PubMedCrossRef
Ruilope LM, Lahera V, Rodicio JL, et al.: Are renal hemodynamics a key factor in the development and maintenance of arterial hypertension in humans? Hypertension 1994, 23:3–9.PubMed
Folkow B: Kidneys in primary hypertension-Initiators, stabilizers or/and victim-aggravators? Blood Press 1994, 3:212–215.PubMed
Perera GA: Hypertensive vascular disease: description and natural history. J Chronic Dis 1995, 1:33–42.CrossRef
Coresh J, Wei GL, McQuillan G, et al.: Prevalence of high blood pressure and elevated serum creatinine level in the United States. Findings from the Third National Health and Nutrition Examination Survey (1988–1994). Arch Intern Med 2001, 161:1207–1216. The prevalence of mild renal insufficiency in the general population is as high as 3% by serum creatinine levels.PubMedCrossRef
Clase CM, Garg AX, Kiberd BA: Prevalence of low glomerular filtration rate in nondiabetic Americans: third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol 2000, 13:1338–1349.CrossRef
National Institute of Diabetes and Digestive and Kidney Diseases: US Renal Data System: Annual Data Report. Bethesda: National Institutes of Health, National Institutes of Diabetes and Digestive and Kidney Diseases; 1989.
Ruilope LM, Alcazar JM, Rodicio JL: Renal consequences of arterial hypertension. J Hypertens 1992, 10(Suppl 7):S85-S90.
Shulman NB, Ford CE, Hall WD, et al.: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function. Results from the Hypertension Detection and Follow-up Program. Hypertension 1989, 13(Suppl I):I–80-I–93.
Cockroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16:13.
Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure: The Sixth report of the Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure (JNV-VI). Arch Intern Med 1997, 157:2413–2446.CrossRef
Brod J, Bahlman J, Cachoven M, Pretschner PD: Development of hypertension in renal disease. Clin Sci 1983, 64:141–152.PubMed
Hall JE: Pathophysiology of obesity hypertension. Curr Hypertens Rep 2000, 2:139–147. A nice review that fits with the aim of this review because obesity is related in a specific manner to proteinuria and renal damage.PubMed
Remuzzi G: Cigarette smoking and renal function impairment. Am J Kidney Dis 1999, 33:807–813.PubMed
Toto RD, Mitchell HC, Smith RD, et al.: "Strict" blood pressure control and progression of renal disease in hypertensive nephrosclerosis. Kidney Int 1995, 48:851–859.PubMed
Peterson JC, Adler S, Burkart JM, et al.: The Modification of Diet in Renal Disease Study. Ann Intern Med 1995, 123:754–762.PubMed
Maschio G, Alberti D, Janin G, et al.: Effect of the angiotensinconverting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. N Eng J Med 1996, 334:939–945.CrossRef
Ruilope LM, Alcazar JM, Hernandez E, et al.: Long-term influences of antihypertensive therapy on microalbuminuria in essential hypertension. Kidney Int 1994, 45(Suppl 45): S171-S173.
Sihm I, Shroeder AP, Aalkjaer C, et al.: Regression of media-tolumen ratio of human subcutaneous arteries and left ventricular hypertrophy during treatment with an angiotensinconverting enzyme inhibitor based regimen in hypertensive patients. Am J Cardiol 1995, 76:38E-40E.PubMed
Schiffrin EL, Deng LY: Comparison of the effects of angiotensin I-converting enzyme inhibition and beta-blockade for 2 years on function of small arteries from hypertensive patients. Hypertension 1995, 25:699–703.PubMed
Segura J, Campo C, Rodicio JL, Ruilope LM: ACE inhibitors and appearance of renal events in hypertensive nephrosclerosis. Hypertension 2001, 38:645–649. This paper shows that ACE inhibitors are positive for renal protection even in the absence of proteinuria.PubMed
- Proteinuria: An underappreciated risk factor in cardiovascular disease
Current Cardiology Reports
Volume 4, Issue 6 , pp 458-462
- Cover Date
- Print ISSN
- Online ISSN
- Current Medicine Group
- Additional Links